Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC for Atrophic Nonunion Fractures
NCT01429012Phase 2Withdrawn
- Sponsor
- University of Liège
- Start
- Nov 2012
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in bone fracture, sponsored by University of Liège. Planned start Nov 2012; status: withdrawn.
02
Drugs
mesenchymal stem cells
03
Conditions
bone fracture
Beyond the preview
Go deeper on NCT01429012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429012.